{
    "xml": "<topic id=\"PHP4475\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/tibolone\" basename=\"tibolone\" title=\"TIBOLONE\">\n<title>TIBOLONE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_737\" namespace=\"/interactions/list-of-drug-interactions/tibolone\">Tibolone</xref>\n</p>\n<data name=\"vtmid\">325567003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_597284177\" title=\"Noretynodrel derivatives\">Noretynodrel derivatives</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP41918\" outputclass=\"indicationsAndDose\" rev=\"1.24\" parent=\"/drugs/tibolone\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Short-term treatment of symptoms of oestrogen deficiency (including women being treated with gonadotrophin releasing hormone analogues)</p>\n<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women at high risk of fractures when other prophylaxis contra-indicated or not tolerated</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41938\" outputclass=\"contraindications\" rev=\"1.28\" parent=\"/drugs/tibolone\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<p>\r\n<ph outputclass=\"contraindication\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"contraindication\">active or recent arterial thromboembolic disease (e.g. angina or myocardial infarction)</ph>; <ph outputclass=\"contraindication\">active thrombophlebitis</ph>; <ph outputclass=\"contraindication\">Dubin-Johnson and Rotor syndrome (or monitor closely)</ph>; <ph outputclass=\"contraindication\">history of breast cancer</ph>; <ph outputclass=\"contraindication\">history of cardiovascular disease</ph>; <ph outputclass=\"contraindication\">history of cerebrovascular disease</ph>; <ph outputclass=\"contraindication\">history of recurrent venous thromboembolism (unless already on anticoagulant treatment)</ph>; <ph outputclass=\"contraindication\">history of thromboembolism</ph>; <ph outputclass=\"contraindication\">history of thrombophlebitis</ph>; <ph outputclass=\"contraindication\">hormone-dependent tumours</ph>; <ph outputclass=\"contraindication\">liver disease (where liver function tests have failed to return to normal)</ph>; <ph outputclass=\"contraindication\">oestrogen-dependent cancer</ph>; <ph outputclass=\"contraindication\">thrombophilic disorder</ph>; <ph outputclass=\"contraindication\">uninvestigated or undiagnosed vaginal bleeding</ph>; <ph outputclass=\"contraindication\">untreated endometrial hyperplasia</ph>; <ph outputclass=\"contraindication\">venous thromboembolism</ph>\r\n</p>\r\n </section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP41947\" outputclass=\"cautions\" rev=\"1.37\" parent=\"/drugs/tibolone\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<p>\r\n<ph outputclass=\"caution\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"caution\">diabetes (increased risk of heart disease)</ph>; <ph outputclass=\"caution\">epilepsy</ph>; <ph outputclass=\"caution\">factors predisposing to thromboembolism</ph>; <ph outputclass=\"caution\">history of breast nodules&#8212;closely monitor breast status (risk of breast cancer)</ph>; <ph outputclass=\"caution\">history of endometrial hyperplasia</ph>; <ph outputclass=\"caution\">history of fibrocystic disease&#8212;closely monitor breast status (risk of breast cancer)</ph>; <ph outputclass=\"caution\">history of liver disease</ph>; <ph outputclass=\"caution\">hypertriglyceridaemia</ph>; <ph outputclass=\"caution\">hypophyseal tumours</ph>; <ph outputclass=\"caution\">migraine (or migraine-like headaches)</ph>; <ph outputclass=\"caution\">presence of antiphospholipid antibodies (increased risk of thrombotic events)</ph>; <ph outputclass=\"caution\">prolonged exposure to unopposed oestrogens may increase risk of developing endometrial cancer</ph>; <ph outputclass=\"caution\">risk factors for oestrogen-dependent tumours (e.g. breast cancer in first-degree relative)</ph>; <ph outputclass=\"caution\">risk of stroke</ph>\r\n</p>\r\n </section>\r\n<section outputclass=\"importantAdvice\">\r\n<title>Cautions, further information</title>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Other conditions</p>\r\n<p>The product literature advises caution in other conditions including hypertension, renal disease, asthma, epilepsy, sickle-cell disease, melanoma, otosclerosis, multiple sclerosis, and systemic lupus erythematosus (but care required if antiphospholipid antibodies present). Evidence for caution in these conditions is unsatisfactory and many women with these conditions may stand to benefit from HRT.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP41915\" outputclass=\"interactions\" rev=\"1.6\" parent=\"/drugs/tibolone\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (tibolone).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41894\" outputclass=\"sideEffects\" rev=\"1.20\" parent=\"/drugs/tibolone\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">facial hair</ph>; <ph outputclass=\"sideEffect\">leucorrhoea</ph>; <ph outputclass=\"sideEffect\">vaginal bleeding</ph>; <ph outputclass=\"sideEffect\">weight changes</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Amnesia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arthralgia</ph>; <ph outputclass=\"sideEffect\">breast cancer</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">increased risk of gall-bladder disease</ph>; <ph outputclass=\"sideEffect\">migraine</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">oedema</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">seborrhoeic dermatitis</ph>; <ph outputclass=\"sideEffect\">symptoms of endometriosis may be exacerbated</ph>; <ph outputclass=\"sideEffect\">uterine fibroids may increase in size</ph>; <ph outputclass=\"sideEffect\">visual disturbances</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Vaginal bleeding</p>\n<p>Investigate for endometrial cancer if bleeding continues beyond 6 months or after stopping treatment.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Reasons to withdraw treatment</p>\n<p>Withdraw treatment if signs of thromboembolic disease, abnormal liver function tests, or signs of cholestatic jaundice.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41912\" outputclass=\"pregnancy\" parent=\"/drugs/tibolone\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid; toxicity in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41951\" outputclass=\"breastFeeding\" parent=\"/drugs/tibolone\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41923\" outputclass=\"hepaticImpairment\" parent=\"/drugs/tibolone\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in acute liver disease or if history of liver disease and liver function tests not returned to normal.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41904\" outputclass=\"renalImpairment\" parent=\"/drugs/tibolone\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"additionalMonitoringInRenalImpairment\">\n<sectiondiv>\n<p>Patients with renal impairment should be closely monitored (risk of fluid retention).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59096\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.21\" parent=\"/drugs/tibolone\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Unsuitable for use in the premenopause (unless being treated with gonadotrophin-releasing hormone analogue) and as (or with) an oral contraceptive.</p>\n<p>Also unsuitable for use within 12 months of last menstrual period (may cause irregular bleeding).</p>\n<p>If transferring from cyclical HRT, start at end of regimen; if transferring from continuous-combined HRT, start at any time.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4475-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/tibolone\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75529\" title=\"Tablet\" namespace=\"/drugs/tibolone/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78400\" namespace=\"/treatment-summaries/sex-hormones\" title=\"Sex hormones\" count=\"4\" rel=\"backlink\">Sex hormones</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_737\" namespace=\"/interactions/list-of-drug-interactions/tibolone\" title=\"Tibolone\" count=\"1\" rel=\"link\">Tibolone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"2\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75529\" namespace=\"/drugs/tibolone/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP4475",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/tibolone",
    "basename": "tibolone",
    "title": "TIBOLONE",
    "interactants": [
        {
            "id": "bnf_int_737",
            "label": "Tibolone"
        }
    ],
    "vtmid": "325567003",
    "drugClassification": [
        "Noretynodrel derivatives"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Short-term treatment of symptoms of oestrogen deficiency (including women being treated with gonadotrophin releasing hormone analogues)",
                        "html": "Short-term treatment of symptoms of oestrogen deficiency (including women being treated with gonadotrophin releasing hormone analogues)"
                    },
                    {
                        "textContent": "Osteoporosis prophylaxis in women at high risk of fractures when other prophylaxis contra-indicated or not tolerated",
                        "html": "Osteoporosis prophylaxis in women at high risk of fractures when other prophylaxis contra-indicated or not tolerated"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "2.5 mg daily.",
                        "html": "<p>2.5&#8239;mg daily.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "contraindications",
                "textContent": "active or recent arterial thromboembolic disease (e.g. angina or myocardial infarction)",
                "html": "active or recent arterial thromboembolic disease (e.g. angina or myocardial infarction)"
            },
            {
                "type": "contraindications",
                "textContent": "active thrombophlebitis",
                "html": "active thrombophlebitis"
            },
            {
                "type": "contraindications",
                "textContent": "Dubin-Johnson and Rotor syndrome (or monitor closely)",
                "html": "Dubin-Johnson and Rotor syndrome (or monitor closely)"
            },
            {
                "type": "contraindications",
                "textContent": "history of breast cancer",
                "html": "history of breast cancer"
            },
            {
                "type": "contraindications",
                "textContent": "history of cardiovascular disease",
                "html": "history of cardiovascular disease"
            },
            {
                "type": "contraindications",
                "textContent": "history of cerebrovascular disease",
                "html": "history of cerebrovascular disease"
            },
            {
                "type": "contraindications",
                "textContent": "history of recurrent venous thromboembolism (unless already on anticoagulant treatment)",
                "html": "history of recurrent venous thromboembolism (unless already on anticoagulant treatment)"
            },
            {
                "type": "contraindications",
                "textContent": "history of thromboembolism",
                "html": "history of thromboembolism"
            },
            {
                "type": "contraindications",
                "textContent": "history of thrombophlebitis",
                "html": "history of thrombophlebitis"
            },
            {
                "type": "contraindications",
                "textContent": "hormone-dependent tumours",
                "html": "hormone-dependent tumours"
            },
            {
                "type": "contraindications",
                "textContent": "liver disease (where liver function tests have failed to return to normal)",
                "html": "liver disease (where liver function tests have failed to return to normal)"
            },
            {
                "type": "contraindications",
                "textContent": "oestrogen-dependent cancer",
                "html": "oestrogen-dependent cancer"
            },
            {
                "type": "contraindications",
                "textContent": "thrombophilic disorder",
                "html": "thrombophilic disorder"
            },
            {
                "type": "contraindications",
                "textContent": "uninvestigated or undiagnosed vaginal bleeding",
                "html": "uninvestigated or undiagnosed vaginal bleeding"
            },
            {
                "type": "contraindications",
                "textContent": "untreated endometrial hyperplasia",
                "html": "untreated endometrial hyperplasia"
            },
            {
                "type": "contraindications",
                "textContent": "venous thromboembolism",
                "html": "venous thromboembolism"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautions",
                "textContent": "diabetes (increased risk of heart disease)",
                "html": "diabetes (increased risk of heart disease)"
            },
            {
                "type": "cautions",
                "textContent": "epilepsy",
                "html": "epilepsy"
            },
            {
                "type": "cautions",
                "textContent": "factors predisposing to thromboembolism",
                "html": "factors predisposing to thromboembolism"
            },
            {
                "type": "cautions",
                "textContent": "history of breast nodules&#8212;closely monitor breast status (risk of breast cancer)",
                "html": "history of breast nodules&#8212;closely monitor breast status (risk of breast cancer)"
            },
            {
                "type": "cautions",
                "textContent": "history of endometrial hyperplasia",
                "html": "history of endometrial hyperplasia"
            },
            {
                "type": "cautions",
                "textContent": "history of fibrocystic disease&#8212;closely monitor breast status (risk of breast cancer)",
                "html": "history of fibrocystic disease&#8212;closely monitor breast status (risk of breast cancer)"
            },
            {
                "type": "cautions",
                "textContent": "history of liver disease",
                "html": "history of liver disease"
            },
            {
                "type": "cautions",
                "textContent": "hypertriglyceridaemia",
                "html": "hypertriglyceridaemia"
            },
            {
                "type": "cautions",
                "textContent": "hypophyseal tumours",
                "html": "hypophyseal tumours"
            },
            {
                "type": "cautions",
                "textContent": "migraine (or migraine-like headaches)",
                "html": "migraine (or migraine-like headaches)"
            },
            {
                "type": "cautions",
                "textContent": "presence of antiphospholipid antibodies (increased risk of thrombotic events)",
                "html": "presence of antiphospholipid antibodies (increased risk of thrombotic events)"
            },
            {
                "type": "cautions",
                "textContent": "prolonged exposure to unopposed oestrogens may increase risk of developing endometrial cancer",
                "html": "prolonged exposure to unopposed oestrogens may increase risk of developing endometrial cancer"
            },
            {
                "type": "cautions",
                "textContent": "risk factors for oestrogen-dependent tumours (e.g. breast cancer in first-degree relative)",
                "html": "risk factors for oestrogen-dependent tumours (e.g. breast cancer in first-degree relative)"
            },
            {
                "type": "cautions",
                "textContent": "risk of stroke",
                "html": "risk of stroke"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Other conditions",
                "textContent": "The product literature advises caution in other conditions including hypertension, renal disease, asthma, epilepsy, sickle-cell disease, melanoma, otosclerosis, multiple sclerosis, and systemic lupus erythematosus (but care required if antiphospholipid antibodies present). Evidence for caution in these conditions is unsatisfactory and many women with these conditions may stand to benefit from HRT.",
                "html": "<p>The product literature advises caution in other conditions including hypertension, renal disease, asthma, epilepsy, sickle-cell disease, melanoma, otosclerosis, multiple sclerosis, and systemic lupus erythematosus (but care required if antiphospholipid antibodies present). Evidence for caution in these conditions is unsatisfactory and many women with these conditions may stand to benefit from HRT.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (tibolone).",
                "html": "<p>Appendix 1 (tibolone).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "facial hair",
                        "html": "facial hair",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "leucorrhoea",
                        "html": "leucorrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vaginal bleeding",
                        "html": "vaginal bleeding",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "weight changes",
                        "html": "weight changes",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Amnesia",
                        "html": "Amnesia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Arthralgia",
                        "html": "Arthralgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "breast cancer",
                        "html": "breast cancer",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-intestinal disturbances",
                        "html": "gastro-intestinal disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "increased risk of gall-bladder disease",
                        "html": "increased risk of gall-bladder disease",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "migraine",
                        "html": "migraine",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "seborrhoeic dermatitis",
                        "html": "seborrhoeic dermatitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "symptoms of endometriosis may be exacerbated",
                        "html": "symptoms of endometriosis may be exacerbated",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "uterine fibroids may increase in size",
                        "html": "uterine fibroids may increase in size",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "visual disturbances",
                        "html": "visual disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Vaginal bleeding",
                "textContent": "Investigate for endometrial cancer if bleeding continues beyond 6 months or after stopping treatment.",
                "html": "<p>Investigate for endometrial cancer if bleeding continues beyond 6 months or after stopping treatment.</p>"
            },
            {
                "type": "advice",
                "title": "Reasons to withdraw treatment",
                "textContent": "Withdraw treatment if signs of thromboembolic disease, abnormal liver function tests, or signs of cholestatic jaundice.",
                "html": "<p>Withdraw treatment if signs of thromboembolic disease, abnormal liver function tests, or signs of cholestatic jaundice.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid; toxicity in animal studies.",
                "html": "<p>Avoid; toxicity in <i>animal</i> studies.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in acute liver disease or if history of liver disease and liver function tests not returned to normal.",
                "html": "<p>Avoid in acute liver disease or if history of liver disease and liver function tests not returned to normal.</p>"
            }
        ]
    },
    "renalImpairment": {
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Patients with renal impairment should be closely monitored (risk of fluid retention).",
                "html": "<p>Patients with renal impairment should be closely monitored (risk of fluid retention).</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Unsuitable for use in the premenopause (unless being treated with gonadotrophin-releasing hormone analogue) and as (or with) an oral contraceptive.\n\nAlso unsuitable for use within 12 months of last menstrual period (may cause irregular bleeding).\n\nIf transferring from cyclical HRT, start at end of regimen; if transferring from continuous-combined HRT, start at any time.",
                "html": "<p>Unsuitable for use in the premenopause (unless being treated with gonadotrophin-releasing hormone analogue) and as (or with) an oral contraceptive.</p><p>Also unsuitable for use within 12 months of last menstrual period (may cause irregular bleeding).</p><p>If transferring from cyclical HRT, start at end of regimen; if transferring from continuous-combined HRT, start at any time.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75529",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78400",
                "label": "Sex hormones",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_737",
                "label": "Tibolone",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75529",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}